ইঙ্গিত
Cytomis is indicated for- Prophylaxis of gastric and duodenal ulceration in NSAID users at high risk of complications from gastric ulcer e.g. the elderly, patients with concomitant debilitating disease and patients with a history of ulcer. Healing of established NSAID- induced gastric and duodenal damage. Healing of gastric and duodenal ulcers in the absence of NSAID therapy. Induction of labor. Prevention and treatment of postpartum hemorrhage.
⚠️ কোনো ওষুধ গ্রহণের আগে সর্বদা নিবন্ধিত চিকিৎসকের পরামর্শ নিন।
ফার্মাকোলজি
Misoprostol is extensively absorbed and rapidly de-esterified to its free acid, which is responsible for its clinical activity and, unlike the parent compound, can be detected in plasma. Peak plasma levels of misoprostol acid are lower when the dose is taken with food, and taking an antacid alongside it reduces the total amount of misoprostol acid available. Misoprostol has both antisecretory action, in that it inhibits gastric acid secretion, and, in animal studies, a protective effect on the stomach lining. NSAIDs inhibit prostaglandin synthesis, and a resulting shortage of prostaglandins in the gastric mucosa can reduce bicarbonate and mucus secretion, contributing to the mucosal damage these drugs cause. Misoprostol can boost bicarbonate and mucus production, but in humans this has only been shown at doses of 200 mcg and above, doses that are also antisecretory. It is therefore not possible to say whether misoprostol's ability to lower the risk of gastric ulcer comes from its antisecretory effect, its protective effect on the mucosa, or both.
Pregnancy & Breastfeeding
Because of the abortifacient property of the Misoprostol component, it is contraindicated in women who are pregnant. It should not be used in women of childbearing potential unless the patient requires nonsteroidal anti-inflammatory drug (NSAID) therapy and is at high risk of developing gastric or duodenal ulceration or for developing complications from gastric or duodenal ulcers associated with the use of the NSAID. In such patients, it may be prescribed if the patient: has had a negative serum pregnancy test within 2 weeks prior to beginning therapy. is capable of complying with effective contraceptive measures. has received both oral and written warnings of the hazards of Misoprostol, the risk of possible contraception failure, and the danger to other women of childbearing potential should the drug be taken by mistake. will begin it only on the second or third day of the next normal menstrual period. Excretion of the active metabolite (Misoprostol acid) into milk is possible but has not been studied. Because of the potential for serious adverse reactions in nursing infants, it is not recommended for use by nursing mothers.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
ডোজ নির্দেশিকা
⚠️ শুধুমাত্র সরকারি উৎস থেকে নির্দেশিকা পরিসীমা। ব্যক্তিগতকৃত ডোজের জন্য আপনার ডাক্তারের পরামর্শ নিন।
পার্শ্বপ্রতিক্রিয়া ও পারস্পরিক ক্রিয়া
পার্শ্বপ্রতিক্রিয়া
No side-effect data recorded yet.